[HTML][HTML] A novel ex vivo model to study therapeutic treatments for myelin repair following ischemic damage
L Werner, M Gliem, N Rychlik, G Pavic… - International Journal of …, 2023 - mdpi.com
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
L Werner, M Gliem, N Rychlik… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
[HTML][HTML] A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
L Werner, M Gliem, N Rychlik, G Pavic… - … Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
L Werner, M Gliem, N Rychlik, G Pavic, L Reiche… - 2023 - universaar.uni-saarland.de
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
L Werner, M Gliem, N Rychlik, G Pavic… - International …, 2023 - search.proquest.com
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
L Werner, M Gliem, N Rychlik, G Pavic, L Reiche… - 2023 - publikationen.sulb.uni-saarland.de
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage.
L Werner, M Gliem, N Rychlik, G Pavic… - … Journal of Molecular …, 2023 - europepmc.org
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage.
L Werner, M Gliem, N Rychlik, G Pavic… - … Journal of Molecular …, 2023 - europepmc.org
Stroke is a major reason for persistent disability due to insufficient treatment strategies
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …
beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent …